Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Patritumab Deruxtecan Phase 2 trial unveils encouraging outcomes in metastatic NSCLC The HERTHENA-Lung01 Phase 2 trial, presented at the 2023 World Conference on Lung Cancer by Daiichi Sankyo, demonstrated… byPallavi MadhirajuSeptember 10, 2023